Literature DB >> 21390970

Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases.

Miriam Rabkin1, Wafaa M El-Sadr.   

Abstract

The dramatic scale-up of HIV services in lower-income countries has led to the development of service delivery models reflecting the specific characteristics of HIV and its treatment as well as local contexts and cultures. Given the shared barriers and challenges faced by health programmes in lower-income countries, many of the implementation approaches developed for HIV programmes have the potential to contribute to the continuity care framework needed to address non-communicable diseases (NCDs) in resource-limited settings. HIV programmes are, in fact, the first large-scale chronic disease programmes in many countries, offering local and effective tools, models and approaches that can be replicated, adapted and expanded. As such, they might be used to 'jumpstart' the development of initiatives to provide prevention, care and treatment services for NCDs and other chronic conditions.

Mesh:

Year:  2011        PMID: 21390970     DOI: 10.1080/17441692.2011.552068

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  75 in total

1.  Inequality in health status among older adults in Africa: the surprising impact of anti-retroviral treatment.

Authors:  Joel Negin; Makandwe Nyirenda; Janet Seeley; Portia Mutevedzi
Journal:  J Cross Cult Gerontol       Date:  2013-12

2.  The importance of social ties in sustaining medication adherence in resource-limited settings.

Authors:  Alexander C Tsai; David R Bangsberg
Journal:  J Gen Intern Med       Date:  2011-12       Impact factor: 5.128

3.  Nurse management of hypertension in rural western Kenya: implementation research to optimize delivery.

Authors:  Rajesh Vedanthan; Jemima H Kamano; Carol R Horowitz; Deborah Ascheim; Eric J Velazquez; Sylvester Kimaiyo; Valentin Fuster
Journal:  Ann Glob Health       Date:  2013-12-25       Impact factor: 2.462

4.  Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice.

Authors:  Rachel Nugent; Ruanne V Barnabas; Ilya Golovaty; Brianna Osetinsky; D Allen Roberts; Cristina Bisson; Lauren Courtney; Pragna Patel; Gerald Yonga; David Watkins
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

Review 5.  Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.

Authors:  Eduard J Beck; Carlos Avila; Sofia Gerbase; Guy Harling; Paul De Lay
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

Review 6.  Antiretroviral therapy for prevention is a combination strategy.

Authors:  Margaret L McNairy; Myron Cohen; Wafaa M El-Sadr
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

Review 7.  Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases.

Authors:  Gerald S Bloomfield; Tracy Y Wang; L Ebony Boulware; Robert M Califf; Adrian F Hernandez; Eric J Velazquez; Eric D Peterson; Jennifer S Li
Journal:  Glob Heart       Date:  2015-03

8.  Cardiovascular disease research and the development agenda in low- and middle-income countries.

Authors:  Melissa S Burroughs Pena; Gerald S Bloomfield
Journal:  Glob Heart       Date:  2015-03

9.  Association between HIV programs and quality of maternal health inputs and processes in Kenya.

Authors:  Margaret E Kruk; Aleksandra Jakubowski; Miriam Rabkin; Davies O Kimanga; Francis Kundu; Travis Lim; Vane Lumumba; Tom Oluoch; Katherine A Robinson; Wafaa El-Sadr
Journal:  Am J Public Health       Date:  2015-02-17       Impact factor: 9.308

Review 10.  Global palliative radiotherapy: a framework to improve access in resource-constrained settings.

Authors:  Shekinah N C Elmore; Surbhi Grover; Jean-Marc Bourque; Supriya Chopra; Anna Mary Nyakabau; Christian Ntizimira; Eric L Krakauer; Tracy A Balboni; Mary K Gospodarowicz; Danielle Rodin
Journal:  Ann Palliat Med       Date:  2019-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.